TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Bimalangshu R. Dey, MD, PhD

Massachusetts General Hospital


Boston, Massachusetts - 02114
  • CLINICAL TRIALS 1
  • CONDITIONS9
  • INTERVENTIONS14
  • SINCE2008
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

January 2008 -
Lymphoma

Multiple Myeloma

Neoplasms, Plasma Cell

Leukemia

Neoplasms

Myelodysplastic Syndromes

Preleukemia

Myeloproliferative Disorders

Graft vs Host Disease

Laboratory Biomarker Analysis

Busulfan

Cyclophosphamide

Cyclosporine

Methotrexate

Tacrolimus

Total-Body Irradiation

Allogeneic Hematopoietic Stem Cell Transplantation

Etoposide

Flow Cytometry

Immunologic Technique

Peripheral Blood Stem Cell Transplantation

Sirolimus

Rasburicase

Related Investigators

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Patrick Y. Wen, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Kay Kehoe, Coordinator

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Jennifer Brown, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

Rachel A. Freedman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Edwin P. Alyea, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

F. Stephen Hodi, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana-Farber Cancer Center

Beth A. Overmoyer, MD, FACP

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo